Skip to content
★ Sign in to follow
PI

ProQuest Investments III, L.P.

Related company / holding
Cadence Pharmaceuticals IncNovadel Pharma Inc
Total declarations
199
Companies
2
▲ Purchases (1 ops.)
€853k
▼ Sales (195 ops.)
€2.6M

Latest filing published 19 Sept 2007 for CADENCE PHARMACEUTICALS INC, €10k.

Insider track record

Disclosed buys
1
Disclosed sells
195
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

ProQuest Investments III, L.P.: trading record in brief

Filings by ProQuest Investments III, L.P. span 2 companies, the busiest being Cadence Pharmaceuticals Inc and Novadel Pharma Inc. The record holds 199 filings, for trades running from 30 October 2006 to 19 September 2007.

On the open market, the record shows 1 purchase worth €853k and 195 sales worth €2.6M. Netting one side against the other leaves €1.8M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 option exercise. So far in 2007, the count stands at 1 purchase and 195 sales.

The newest entry dates from 19 September 2007: an open-market sale of €10k, in Cadence Pharmaceuticals Inc. The last insider purchase was made public on 26 January 2007, 7,226 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to ProQuest Investments III, L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations199 total

25 of 199 declarations